11 results  1 of 1 

1 miR-155, miR-191, and miR-494 as diagnostic biomarkers for oral squamous cell carcinoma and the effects of Avastin on these biomarkers
Naghmeh Emami, Abdolreza Mohamadnia, Masoumeh Mirzaei, Mohammad Bayat, Farnoush Mohammadi, Naghmeh Bahrami
J Korean Assoc Oral Maxillofac Surg.2020;46(5):341-347.   Published online 2020 October 31     DOI: http://dx.doi.org/10.5125/jkaoms.2020.46.5.341
      
2 Effect of Primary Intravitreal Bevacizumab Injection on Stage 3 Retinopathy of Prematurity with Plus Signs
Sung Eun Kim, Tyler Hyung Taek Rim, Christopher Seungkyu Lee
J Korean Ophthalmol Soc.2015;56(1):62-69.   Published online 2015 January 16     DOI: http://dx.doi.org/10.3341/jkos.2015.56.1.62
      
3 The Change of Microaneurysm in Diabetic Retinopathy Patients Who Undergo Intravitreal Avastin (Bevacizumab) Injection
Chang Wook Choi, Seung Joon Lee, Hye Ra Kang, Yun Sik Yang
J Korean Ophthalmol Soc.2014;55(10):1481-1486.   Published online 2014 October 15     DOI: http://dx.doi.org/10.3341/jkos.2014.55.10.1481
      
4 Stability and Sterility of Bevacizumab after Withdrawal into a Syringe and Refrigeration or Freezing
Gwang Myung Noh, Soo Young Kim, Ki Yup Nam, Seung Uk Lee, Young Ho Kim, Sang Joon Lee
J Korean Ophthalmol Soc.2014;55(10):1499-1503.   Published online 2014 October 15     DOI: http://dx.doi.org/10.3341/jkos.2014.55.10.1499
      
5 Effects of Intravitreal Bevacizumab Injection in 3 Types of Macular Edema Secondary to Branch Retinal Vein Occlusion
Yoon Soo Jang, Dong Won Lee
J Korean Ophthalmol Soc.2012;53(8):1112-1117.   Published online 2012 August 17     DOI: http://dx.doi.org/10.3341/jkos.2012.53.8.1112
      
6 Anatomical Non-Responder to Intravitreal Bevacizumab for Neovascular Age-Related Macular Degeneration
Sung Woo Cho, Jeong Hun Bae, Su Jeong Song
J Korean Ophthalmol Soc.2010;51(11):1464-1470.   Published online 2010 November 22     DOI: http://dx.doi.org/10.3341/jkos.2010.51.11.1464
      
7 Effectiveness of Preoperative Intravitreal Bevacizumab Injections in Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy
Gang Seok Jeon, Jae Ryong Han, Woo Ho Nam, Ha Kyoung Kim
J Korean Ophthalmol Soc.2009;50(8):1221-1225.   Published online 2009 August 21     DOI: http://dx.doi.org/10.3341/jkos.2009.50.8.1221
      
8 Intravitreal Bevacizumab Injection as Preoperative Adjuvant of Vitrectomy for Proliferative Diabetic Retinopathy
Min Kyu Shin, Na Mi Kim, Ji Eun Lee, Boo Sup Oum
J Korean Ophthalmol Soc.2009;50(5):731-737.   Published online 2009 May 20     DOI: http://dx.doi.org/10.3341/jkos.2009.50.5.731
      
9 Long-term Effect of Intravitreal Bevacizumab for CNV Secondary to Age-Related Macular Degeneration
Yong Hwan Kim, Eung Suk Kim, Seung Young Yu, Hyung Woo Kwak
J Korean Ophthalmol Soc.2008;49(12):1935-1940.   Published online 2008 December 30     DOI: http://dx.doi.org/10.3341/jkos.2008.49.12.1935
      
10 Results of Intravitreal Bevacizumab for Macular Edema with Retinal Vein Occlusion and Diabetic Macular Edema
Jong Youn Kim, Eui Yong Kweon, Dong Wook Lee, Nam Chun Cho
J Korean Ophthalmol Soc.2008;49(8):1275-1282.   Published online 2008 August 20     DOI: http://dx.doi.org/10.3341/jkos.2008.49.8.1275
      
11 Two Cases of Subconjunctival Bevacizumab Injection to Prevent Bleb Failure After Trabeculectomy
Dong Wook Lee, Dae-Gyu Lee
J Korean Ophthalmol Soc.2008;49(8):1345-1349.   Published online 2008 August 20     DOI: http://dx.doi.org/10.3341/jkos.2008.49.8.1345
      

 1 of 1